Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 7
2018 9
2019 4
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Bulk and Single-Cell Next-Generation Sequencing: Individualizing Treatment for Colorectal Cancer.
Kyrochristos ID, Ziogas DE, Goussia A, Glantzounis GK, Roukos DH. Kyrochristos ID, et al. Cancers (Basel). 2019 Nov 18;11(11):1809. doi: 10.3390/cancers11111809. Cancers (Basel). 2019. PMID: 31752125 Free PMC article. Review.
Precision in personalized prediction-based medicine.
Kyrochristos ID, Ziogas DE, Roukos DH. Kyrochristos ID, et al. Per Med. 2018 Nov;15(6):467-470. doi: 10.2217/pme-2018-0079. Epub 2018 Nov 2. Per Med. 2018. PMID: 30387685 Review. No abstract available.
Early solid tumor diagnosis through next-generation sequencing of cell-free DNA.
Ziogas DE, Kyrochristos ID, Lykoudis EG, Roukos DH. Ziogas DE, et al. Among authors: kyrochristos id. Biomark Med. 2018 Nov;12(11):1197-1201. doi: 10.2217/bmm-2018-0269. Epub 2018 Oct 31. Biomark Med. 2018. PMID: 30379093 Free article. Review. No abstract available.
Precise predictive and therapeutic strategy for breast cancer.
Kyrochristos ID, Peristeri DV, Ziogas DE, Lykoudis EG, Roukos DH. Kyrochristos ID, et al. Future Oncol. 2018 Aug;14(18):1777-1780. doi: 10.2217/fon-2018-0277. Epub 2018 May 30. Future Oncol. 2018. PMID: 29846090 Free article. No abstract available.
Breast cancer genome analysis in time and space: biomarker development strategy.
Kyrochristos ID, Ziogas DE, Lykoudis EG, Roukos DH. Kyrochristos ID, et al. Biomark Med. 2018 Jun;12(6):547-550. doi: 10.2217/bmm-2018-0109. Epub 2018 Jun 6. Biomark Med. 2018. PMID: 29873520 Free article. No abstract available.
Next-generation sequencing: from conventional applications to breakthrough genomic analyses and precision oncology.
Ziogas DE, Kyrochristos ID, Roukos DH. Ziogas DE, et al. Among authors: kyrochristos id. Expert Rev Med Devices. 2018 Jan;15(1):1-3. doi: 10.1080/17434440.2017.1419059. Epub 2017 Dec 28. Expert Rev Med Devices. 2018. PMID: 29284319 Review. No abstract available.
Discovering novel valid biomarkers and drugs in patient-centric genomic trials: the new epoch of precision surgical oncology.
Ziogas DE, Kyrochristos ID, Roukos DH. Ziogas DE, et al. Among authors: kyrochristos id. Drug Discov Today. 2018 Nov;23(11):1848-1872. doi: 10.1016/j.drudis.2018.07.008. Epub 2018 Aug 2. Drug Discov Today. 2018. PMID: 30077778 Review.
Drug resistance: origins, evolution and characterization of genomic clones and the tumor ecosystem to optimize precise individualized therapy.
Kyrochristos ID, Ziogas DE, Roukos DH. Kyrochristos ID, et al. Drug Discov Today. 2019 Jun;24(6):1281-1294. doi: 10.1016/j.drudis.2019.04.008. Epub 2019 Apr 19. Drug Discov Today. 2019. PMID: 31009757 Review.
20 results
Jump to page
Feedback